IL6 and pancreatitis: ET-1 is considered a risk factor for pancreatic diseases, especially acute ischemia and pancreatitis, as it induces the secretion of pro-inflammatory cytokines (IL-1, IL-6), which exacerbate existing pancreatitis and lead to disease progression [101].